References

Clinical profile and genomic characterization of the 2026 Bundibugyo virus index case in Uganda

10.1038/s41591-026-04510-7 · 2026 · External reference

Bundibugyo virus outbreak: when a concerning pathogen meets a humanitarian emergency

10.1038/s41579-026-01332-9 · 2026 · External reference

Bundibugyo virus-perspectives for the current outbreak

10.1038/s44298-026-00204-6 · 2026 · External reference

Modeled scenario projections for the Ebola disease outbreak caused by Bundibugyo virus, 2026

10.15585/mmwr.mm7522e1 · 2026 · External reference

After Marburg, Ebola

10.1016/s0140-6736(77)92008-6 · 1977 · External reference

Structure and assembly of the Ebola virus nucleocapsid

10.1038/nature24490 · 2017 · External reference

Ebola virus disease

10.1038/s41572-020-0147-3 · 2020 · External reference

The Ebola virus - going beyond the bleeding edge

10.1099/jmm.0.001998 · 2025 · External reference

Clinical factors associated with mortality in ebola virus disease: a systematic review and meta-analysis

10.1186/s12879-026-13587-x · 2026 · External reference

An exploration of the spatiotemporal and demographic patterns of Ebola virus disease epidemic in West Africa using open access data sources

10.1016/j.apgeog.2017.10.003 · 2018 · External reference

Ebola virus disease: an update on post-exposure prophylaxis

10.1016/s1473-3099(17)30677-1 · 2018 · External reference

Ebola virus disease: biological and diagnostic evolution from 2014 to 2017

10.1016/j.medmal.2017.11.002 · 2018 · External reference

Achievements and challenges in therapy and vaccines development of viral hemorrhagic fevers: an up-to-date review

10.3390/pharmaceutics18040426 · 2026 · External reference

Oral immunization with virus-like particles elicits Ebola virus-specific humoral and cellular immune responses in mice

10.1016/j.vaccine.2026.128764 · 2026 · External reference

Treatment of Ebola virus disease: from serotherapy to the use of monoclonal antibodies

10.3390/antib14010022 · 2025 · External reference

The ongoing evolution of antibody-based treatments for Ebola virus infection

10.2217/imt-2017-0010 · 2017 · External reference

Development of an antibody cocktail for treatment of Sudan virus infection

10.1073/pnas.1914985117 · 2020 · External reference

Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis

10.1016/s2666-5247(22)00123-9 · 2022 · External reference

Remdesivir, mAb114, REGN-EB3, and ZMapp partially rescue nonhuman primates infected with a low passage Kikwit variant of Ebola virus

10.1038/s41467-025-59168-5 · 2025 · External reference

Fc effector functions in RNA viral infections: mechanisms of antiviral immunity and implications for vaccine design

10.3389/fimmu.2026.1772257 · 2026 · External reference

Monoclonal IgM antibodies mediate potent complement neutralization by targeting cell-derived epitopes on enveloped viruses

10.1128/mbio.01709-25 · 2026 · External reference

A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodies

10.1038/s44298-026-00192-7 · 2026 · External reference

A highly potent and broadly accessible bispecific nanobody for the treatment of ebola virus infections

10.1371/journal.ppat.1013878 · 2026 · External reference

Nanobody targeting glycan cap confers broad orthoebolavirus neutralization

10.1016/j.virs.2026.03.018 · 2026 · External reference

Knowledge mapping and research trends of chimeric antigen receptor T-cell immunotherapy in breast cancer: a bibliometric and visual analytics study

10.1080/21645515.2026.2690841 · 2026 · External reference

A data-driven analysis of artificial intelligence applications in depression research: 2020-2025

10.1016/j.ajp.2026.104978 · 2026 · External reference

Global trends and research hotspots in autoimmune encephalitis: insights from a bibliometric and visualized analysis: 1971-2025

10.3389/fimmu.2026.1798782 · 2026 · External reference

A bibliometric analysis of vaccine research on Chikungunya virus: contributors, trends, and emerging frontiers

10.3389/fimmu.2025.1692556 · 2025 · External reference

From synapse to strategy: a bibliometric map of ionotropic glutamate receptors in depression

10.1007/s00210-026-05353-2 · 2026 · External reference

The health impact of the 2014-15 Ebola outbreak

10.1016/j.puhe.2016.10.020 · 2017 · External reference

Knowledge, attitude, and practice of use of safety precautions among health care workers in a Nigerian tertiary hospital, 1 year after the Ebola virus disease epidemic

10.1016/j.aogh.2016.07.004 · 2016 · External reference

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

10.1038/nature13777 · 2014 · External reference

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease

10.1073/pnas.1200409109 · 2012 · External reference

Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies

10.1126/scitranslmed.3003876 · 2012 · External reference

A randomized, controlled trial of ZMapp for Ebola virus infection

10.1056/nejmoa1604330 · 2016 · External reference

A randomized, controlled trial of Ebola virus disease therapeutics

10.1056/nejmoa1910993 · 2019 · External reference

Ebanga: The most recent FDA-approved drug for treating Ebola

10.3389/fphar.2023.1083429 · 2023 · External reference

Cryo-EM structures of Měnglà virus GP reveal combined Ebola- and Marburg-like epitope masking strategies for antibody evasion

10.1073/pnas.2529436123 · 2026 · External reference

Engineered bispecific antibodies achieve broad and potent protection against multiple ebolavirus species

10.1080/22221751.2026.2668755 · 2026 · External reference

A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus

10.1016/j.immuni.2021.03.009 · 2021 · External reference

Antibody treatment of Ebola and Sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site

10.1016/j.celrep.2016.04.026 · 2016 · External reference

Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles

10.1093/infdis/jir295 · 2011 · External reference

Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system

10.1038/s42003-024-06556-0 · 2024 · External reference

Antibody-dependent enhancement of Ebola virus infection by human antibodies isolated from survivors

10.1016/j.celrep.2018.07.035 · 2018 · External reference

Engineering antibody-armed oncolytic viruses: design strategies, synergistic mechanisms, and clinical translation

10.3389/fimmu.2026.1805770 · 2026 · External reference

It takes a matured mAb to treat Ebolavirus infection

10.1016/j.chom.2018.12.013 · 2019 · External reference

A review of broadly protective monoclonal antibodies to treat Ebola virus disease

10.1016/j.coviro.2023.101339 · 2023 · External reference

Antibody-dependent natural killer cell activation after Ebola vaccination

10.1093/infdis/jiz657 · 2021 · External reference

Review: Insights on current FDA-approved monoclonal antibodies against Ebola virus infection

10.3389/fimmu.2021.721328 · 2021 · External reference

Recent successes in therapeutics for Ebola virus disease: no time for complacency

10.1016/s1473-3099(20)30282-6 · 2020 · External reference

Ebola outbreak caused by Bundibugyo virus: challenges and priorities for epidemic preparedness and response

10.1016/s0140-6736(26)01141-4 · 2026 · External reference

Design of universal Ebola virus vaccine candidates via immunofocusing

10.1073/pnas.2316960121 · 2024 · External reference

Development of a human antibody cocktail that deploys multiple functions to confer pan-ebolavirus protection

10.1016/j.chom.2018.12.004 · 2019 · External reference

A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates

10.1016/j.chom.2018.12.005 · 2019 · External reference